Dr Teresa Sadras
Honorary (Senior Fellow)
The Sir Peter MacCallum Department of Oncology
47 Scholarly works
3 Projects
HIGHLIGHTS
2026
Journal article
IRF2BP2::JAK2 Defines a Novel Kinase-Activating Fusion in Pediatric T-Cell Acute Lymphoblastic Leukemia
DOI: 10.1002/gcc.701122025
Journal article
A novel TRKB-activating internal tandem duplication characterizes a new mechanism of receptor tyrosine kinase activation
DOI: 10.1038/s41698-025-00928-32025
Journal article
CEACAM1 as a mediator of B-cell receptor signaling in mantle cell lymphoma
DOI: 10.1038/s41467-025-60208-32025
Journal article
Abstract A023-PR006: CBL mutations in pediatric solid and CNS tumours are a marker of receptor tyrosine kinase activation and a potential therapeutic target
DOI: 10.1158/1538-7445.pediatric25-a023-pr0062025
Journal article
Generative AI and digital twins: shaping a paradigm shift from precision to truly personalized medicine
DOI: 10.1080/17460441.2025.25073762024
Research grants (ARC, NHMRC, MRFF)
Recovering Lost Therapeutic Opportunities in High-Risk Paediatric Cancer-Novel Drivers of Receptor Tyrosine Kinase Activation
2022
Research Grant
Investigating Mechanistic Basis of Therapy-Resistance in High-Risk Acute Lymphoblastic Leukemia
RECENT SCHOLARLY WORKS
2024
Journal article
Principles of CRISPR-Cas13 mismatch intolerance enable selective silencing of point-mutated oncogenic RNA with single-base precision
DOI: 10.1126/sciadv.adl07312024
Journal article
Co-Targeting BCL-2 and MCL1 (via CDK9) in Pre-Clinical Models of High-Risk Acute Lymphoblastic Leukemia
DOI: 10.1182/blood-2024-2027572024
Journal article
Putting function back into paediatric cancer genomics - modelling the therapeutic implications of novel genomic features
DOI: 10.1158/1538-7445.PEDIATRIC24-B0042024
Journal article
A novel NTRK2-activating internal tandem duplication characterizes a new mechanism of receptor tyrosine kinase activation
DOI: 10.1158/1538-7445.PEDIATRIC24-B0022024
Conference Proceedings
CRISPR-DIRECTED CHROMOSOMALTRANSLOCATIONS PROVIDE NOVEL INSIGHTS INTO LEUKEMIA BIOLOGY
RECENT PROJECTS
2025
Research contracts (non-grants)
Uncovering Actionable Targets and Resistance Mechanisms in Relapsed/Refractory B-All Lacking CD19